Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Veure altres versions (1)

BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...

Descripció completa

Dades bibliogràfiques
Autors principals: Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R
Format: Journal article
Idioma:English
Publicat: 2011

Ítems similars